EAACI

Groundbreaking Study Validates Allergen Exposure Chamber for Assessing Clinical Outcomes of HDM AIT in Allergic Rhinoconjunctivitis Patients’

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — A study conducted by researchers from the ALL-MED Medical Research Institute and the Department of Clinical Immunology at Wroclaw Medical University in Poland has validated the use of an allergen exposure chamber (AEC) in assessing the clinical outcomes of house dust mite (HDM) allergen immunotherapy (AIT) in patients with allergic … Read more

Studie zeigt vielversprechende Ergebnisse für Immuntherapie gegen Hautkrebs

by

HAMBURG, Deutschland, 11. Juni 2023 /PRNewswire/ — Eine bahnbrechende Studie wurde am 10. Juni auf dem Hybridkongress in Hamburg vorgestellt, der von der European Academy of Allergy and Clinical Immunology (EAACI) organisiert wurde. Die von Forschern des King’s College London und des Guy’s and St Thomas’ NHS Foundation Trust durchgeführte Studie hat vielversprechende Ergebnisse für … Read more

New Adaptive Trial Design Supports Evaluation of Therapeutic Strategies for Allergic Patients

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — Allergic rhinitis (AR) and rhinoconjunctivitis, common chronic inflammatory allergic diseases affecting the upper respiratory tract, have a significant impact on the global population. The prevalence of AR ranges from 17% to 29% in Europe and up to 20% in the United States, with seasonal allergic rhinitis (SAR) affecting up … Read more

Study Shows Promising Results for Immunotherapy Targeting Skin Cancer

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — A ground-breaking study was presented 10 June at the Hybrid Congress in Hamburg organized by the European Academy of Allergy & Clinical Immunology (EAACI). Study was conducted by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust has revealed promising results for a new … Read more